DOCSLIB.ORG

Conference Program and Schedule

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Conference Program and Schedule 02_BCR11_front_Layout 1 8/30/11 2:25 PM Page 10 Conference Program and Schedule Wednesday, September 14 Special Opening Lecture: Cancer genomes and their implications for basic 6:00 p.m.-7:00 p.m. and applied research* Keynote Lecture Bert Vogelstein, Johns Hopkins Sidney Kimmel Grand Ballroom Comprehensive Cancer Center, Baltimore, MD Opening remarks Discovery in cancer genomics by next-generation sequencing Conference Chairperson: Elizabeth H. Blackburn, and data analysis* University of California, San Francisco, CA Elaine Mardis, Washington University School of Medicine, St. Louis, MO Building molecules to guide anticancer therapy* Insights into tumor biology and therapeutic resistance from Roger Y. Tsien, University of California, San Diego, systematic genetic studies La Jolla, CA Levi A. Garraway, Dana-Farber Cancer Institute, Boston, MA 7:00 p.m.-8:30 p.m. 10:00 a.m.-10:30 a.m. Opening Welcome Reception Break InterContinental Ballroom 10:30 a.m.-12:30 p.m. Session 2: Cancer as an Organ Grand Ballroom Thursday, September 15 Chairperson: Zena Werb, University of California, 7:00 a.m.-8:00 a.m. San Francisco, CA Continental Breakfast Normalizing the tumor microenvironment to enhance Pacific Terrace therapeutic outcome* Rakesh K. Jain, Massachusetts General Hospital, Boston, MA Meet-the-Expert Roundtables † Jackson, Howard, and Fremont The role of nitric oxide in tumor microenvironment* Dai Fukumura, Massachusetts General Hospital, Boston, MA †Advance sign up is required at Registration in the Grand Ballroom Foyer. DNA-damaging anticancer therapies modify the tumor microenvironment* Judith Campisi, Buck Institute for Age Research, Novato, CA 8:00 a.m.-10:00 a.m. Session 1: Understanding the Cancer Genome Direct signaling between platelets and cancer cells Grand Ballroom induces an epithelial-mesenchymal-like transition and promotes metastasis** Chairperson: David P. Lane, Agency for Science, Myriam Labelle, Koch Institute for Integrative Cancer Research Technology, and Research (A*STAR), Singapore at MIT, Cambridge, MA *An extended abstract for this presentation is available in the Invited Abstracts section of the Proceedings. **Short talks from proffered papers. 10 American Association for Cancer Research • Program and Proceedings 02_BCR11_front_Layout 1 8/30/11 2:25 PM Page 11 Conference Program and Schedule A genetic screen for novel determinants of anoikis resistance Friday, September 16 identifies PVRL4** Natalya N. Pavlova, Harvard Medical School, Boston, MA 7:00 a.m.-8:00 a.m. Continental Breakfast Pacific Terrace 12:30 p.m.-2:00 p.m. Lunch on own Meet-the-Expert Roundtables † Jackson, Howard, and Fremont Mentoring Roundtables † Jackson, Howard, and Fremont †Advance sign up is required at Registration in the Grand Ballroom Foyer. †Advance sign up is required at Registration in the Grand Ballroom Foyer. 8:00 a.m.-10:00 a.m. 2:00 p.m.-4:00 p.m. Session 4: Genomic Instability and Genome Surveillance Session 3: Immunomodulation Grand Ballroom Grand Ballroom Chairperson: Elizabeth H. Blackburn, University of California, Chairperson: Dai Fukumura, Massachusetts General Hospital, San Francisco, CA Boston, MA How the p53 pathway controls the response to chemotherapy* Immune checkpoint blockade in cancer therapy: David P. Lane, Agency for Science, Technology, and Research New insights and opportunities (A*STAR), Singapore James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Exploiting cell cycle checkpoint control in cancer therapy Helen M. Piwnica-Worms, Washington University School of Blockade of immunologic checkpoints in cancer therapy: The Medicine, St. Louis, MO B7-H1/PD-1 pathway* Suzanne L. Topalian, Johns Hopkins University, Baltimore, MD Targeting the Fanconi anemia/BRCA pathway in cancer therapy* Alan D. D’Andrea, Dana-Farber Cancer Institute, Boston, MA Natural killer cells in host defense against cancer* Lewis L. Lanier, University of California, San Francisco, CA The BLM helicase facilitates RNA polymerase I-mediated ribosomal RNA transcription** Patrick Grierson, The Ohio State University College of Medicine, Columbus, OH 4:30 p.m.-7:30 p.m. Poster Session A and Reception Regulation of the Fanconi anemia pathway by a SUMO-like InterContinental Ballroom delivery network** Kailin Yang, Dana-Farber Cancer Institute, Harvard Medical See detailed listing for Poster Session A beginning on page 17. School, Boston, MA *An extended abstract for this presentation is available in the Invited Abstracts section of the Proceedings. **Short talks from proffered papers. Frontiers in Basic Cancer Research • September 14-18, 2011 • San Francisco, CA 11 02_BCR11_front_Layout 1 8/30/11 2:25 PM Page 12 Conference Program and Schedule 10:00 a.m.-10:30 a.m. 12:30 p.m.-2:00 p.m. Break Lunch on own Mentoring Roundtables † Jackson, Howard, and Fremont 10:30 a.m.-12:30 p.m. Session 5: Risk Factors †Advance sign up is required at Registration in the Grand Grand Ballroom Ballroom Foyer. Chairperson: Helen M. Piwnica-Worms, Washington University School of Medicine, St. Louis, MO 2:00 p.m.-4:00 p.m. New insights into the microenvironment and metastasis* Session 6: Reprogramming Zena Werb, University of California, San Francisco, CA and Plasticity of Cancer Stem Cells Grand Ballroom Systems genetics analysis of cancer susceptibility Allan Balmain, UCSF Helen Diller Family Comprehensive Chairperson: Judith Campisi, Buck Institute for Age Cancer Center, San Francisco, CA Research, Novato, CA Ribosomal protein-Mdm2-p53 signaling and metabolism Induction of pluripotency by defined factors* Yanping Zhang, University of North Carolina, Chapel Hill, NC Shinya Yamanaka, Kyoto University, Kyoto, Japan Human Merkel cell polyomavirus causes Merkel cell Stem cell self-renewal and cancer cell proliferation carcinoma: Implication of viral etiology in human cancers** Sean J. Morrison, University of Michigan, Ann Arbor, MI Huichen Feng, University of Pittsburgh Cancer Institute, Pittsburgh, PA Reprogramming cell fate by mimicking natural mechanisms* Helen M. Blau, Stanford University School of Medicine, Why redheads are at increased risk of melanoma: A novel Stanford, CA BRAF mutant mouse model** Devarati Mitra, Harvard Medical School, Massachusetts The complexity of tumor cell hierarchies* General Hospital, Boston, MA Jeremy N. Rich, The Cleveland Clinic, Cleveland, OH 4:30 p.m.-7:30 p.m. Poster Session B and Reception InterContinental Ballroom See detailed listing for Poster Session B beginning on page 21. *An extended abstract for this presentation is available in the Invited Abstracts section of the Proceedings. **Short talks from proffered papers. 12 American Association for Cancer Research • Program and Proceedings 02_BCR11_front_Layout 1 8/30/11 2:25 PM Page 13 Conference Program and Schedule Saturday, September 17 10:00 a.m.-10:30 a.m. Break 7:00 a.m.-8:00 a.m. Continental Breakfast Pacific Terrace 10:30 a.m.-12:30 p.m. Session 8: Metabolism and Autophagy Meet-the-Expert Roundtables † Grand Ballroom Jackson, Howard, and Fremont Chairperson: William G. Kaelin, Jr., Dana-Farber Cancer †Advance sign up is required at Registration in the Grand Institute, Boston, MA Ballroom Foyer. Role of autophagy and cellular metabolism in cancer Eileen P. White, UMDNJ-The Cancer Institute of New Jersey, 8:00 a.m.-10:00 a.m. New Brunswick, NJ Session 7: Emerging Technologies for Cancer Research Grand Ballroom Oncogene regulation of the autophagy machinery* Beth C. Levine, University of Texas Southwestern Medical Chairperson: Scott Manalis, Massachusetts Institute of Center, Dallas, TX Technology, Cambridge, MA 2-Oxoglutarate-dependent dioxygenases: Potential links Measuring evolution in neoplasms* between altered metabolism and cancer Carlo Maley, University of California, San Francisco, CA William G. Kaelin, Jr. Technologies for detecting and analyzing proteins in living cells* PICT1/GLTSCR2 is a critical nucleolar binding partner of RPL11 Alice Y. Ting, Massachusetts Institute of Technology, that regulates the MDM2-p53 pathway and tumor growth** Cambridge, MA Kohichi Kawahara, Kyushu University, Fukuoka, Japan Microfluidic measurements of single cell mass reveal how A mechanistic investigation into the dynamic alliance between growth and division are coordinated* autophagy and tumor suppression in prostate cancer** Scott Manalis Lorena A. Puto, Salk Institute, La Jolla, CA An oncolytic vaccinia virus encoding the human sodium iodide symporter facilitates long-term deep tissue image monitoring of virotherapy and targeted radiotherapy of pancreatic cancer** 12:30 p.m.-2:00 p.m. Dana Haddad, Memorial Sloan-Kettering Cancer Center, New Lunch on own York, NY Mentoring Roundtables † From prediction to prognosis and therapeutics: The power of Jackson, Howard, and Fremont breast cancer transcriptional networks** †Advance sign up is required at Registration in the Grand Bin Zhang, Sage Bionetworks, Seattle, WA Ballroom Foyer. *An extended abstract for this presentation is available in the Invited Abstracts section of the Proceedings. **Short talks from proffered papers. Frontiers in Basic Cancer Research • September 14-18, 2011 • San Francisco, CA 13 02_BCR11_front_Layout 1 8/30/11 2:25 PM Page 14 Conference Program and Schedule 2:00 p.m.-4:00 p.m. Sunday, September 18 Session 9: Epigenetics and Cancer Grand Ballroom 7:00 a.m.-8:00 a.m. Continental Breakfast Chairperson: Helen M. Blau, Stanford University School of Pacific Terrace Medicine, Stanford, CA Meet-the-Expert Roundtables † DNA methylation and nucleosome repositioning in cancer* Jackson, Howard,
Load more

Recommended publications
  • 書 名 等 発行年 出版社 受賞年 備考 N1 Ueber Das Zustandekommen Der
    書 名 等 発行年 出版社 受賞年 備考 Ueber das Zustandekommen der Diphtherie-immunitat und der Tetanus-Immunitat bei thieren / Emil Adolf N1 1890 Georg thieme 1901 von Behring N2 Diphtherie und tetanus immunitaet / Emil Adolf von Behring und Kitasato 19-- [Akitomo Matsuki] 1901 Malarial fever its cause, prevention and treatment containing full details for the use of travellers, University press of N3 1902 1902 sportsmen, soldiers, and residents in malarious places / by Ronald Ross liverpool Ueber die Anwendung von concentrirten chemischen Lichtstrahlen in der Medicin / von Prof. Dr. Niels N4 1899 F.C.W.Vogel 1903 Ryberg Finsen Mit 4 Abbildungen und 2 Tafeln Twenty-five years of objective study of the higher nervous activity (behaviour) of animals / Ivan N5 Petrovitch Pavlov ; translated and edited by W. Horsley Gantt ; with the collaboration of G. Volborth ; and c1928 International Publishing 1904 an introduction by Walter B. Cannon Conditioned reflexes : an investigation of the physiological activity of the cerebral cortex / by Ivan Oxford University N6 1927 1904 Petrovitch Pavlov ; translated and edited by G.V. Anrep Press N7 Die Ätiologie und die Bekämpfung der Tuberkulose / Robert Koch ; eingeleitet von M. Kirchner 1912 J.A.Barth 1905 N8 Neue Darstellung vom histologischen Bau des Centralnervensystems / von Santiago Ramón y Cajal 1893 Veit 1906 Traité des fiévres palustres : avec la description des microbes du paludisme / par Charles Louis Alphonse N9 1884 Octave Doin 1907 Laveran N10 Embryologie des Scorpions / von Ilya Ilyich Mechnikov 1870 Wilhelm Engelmann 1908 Immunität bei Infektionskrankheiten / Ilya Ilyich Mechnikov ; einzig autorisierte übersetzung von Julius N11 1902 Gustav Fischer 1908 Meyer Die experimentelle Chemotherapie der Spirillosen : Syphilis, Rückfallfieber, Hühnerspirillose, Frambösie / N12 1910 J.Springer 1908 von Paul Ehrlich und S.
    [Show full text]
  • Creating New Value
    OECD Learning Compass 2030 Transformative Competencies Creating New Value Shinya Yamanaka Professor, Kyoto University Director of the Center for iPS Cell Research and Application (CiRA) 2012 Nobel Prize in Physiology or Medicine Award Winner Kyoto, Japan OECD Learning Compass 2030 Transformative Competencies: Creating New Value Shinya Yamanaka1 Professor, Kyoto University Director of the Center for iPS Cell Research and Application (CiRA) 2012 Nobel Prize in Physiology or Medicine Award Winner Kyoto, Japan I believe that “creating new value”, as articulated by the For students who aspire to become scientists, it is OECD Learning Compass 2030, is a competency that important to reiterate that the natural world is still full of every student needs for the future. This is especially true “unknowns”. The mission of scientists is to discover these for aspiring scientists. unknowns. In much the same way that artists use free thinking to create unique works on a blank canvas, One of the most important competencies in science is the scientists use their free thinking to develop and test willingness to doubt commonly accepted theories. unique hypotheses about unknowns. Such discoveries Scientists must be able to think for themselves, without can contribute to society in significant ways, through believing 100% of what textbooks and teachers tell advancements in science and technology, but they also them. It is with this mind-set that people generate new involve potential risks and threats to humans. Scientists ideas. This is particularly important today, given the must therefore have high ethical standards, as well. I breakneck pace at which developments in science and sincerely hope that many children will develop an technology are advancing; and it will only become more interest in the natural sciences and grow up to become important as progress accelerates further.
    [Show full text]
  • Shinya Yamanaka Is Focused on Daily Efforts to Realize Clinical Applications of Ips Cells As Soon As Possible and Deliver the Benefits to Patients
    Director, Center for iPS Cell Research President & Chief Executive Officer, and Application (CiRA), Kyoto University The Norinchukin Bank Shinya Yamanaka is focused on daily efforts to realize clinical applications of iPS cells as soon as possible and deliver the benefits to patients. Despite busy days traveling not only nationwide frequently but also between Japan and the United States every month, Dr. Yamanaka maintains an exercise routine of running. His favorite running course during his frequent Tokyo visits is the area surrounding the Imperial Palace. At our request, he stopped by The Norinchukin Bank’s Head Office, which faces the moat of the Imperial Palace, for a talk with Kazuto Oku, who recently became President & Chief Executive Officer of The Norinchukin Bank. 8 prising that you run almost every day. Status of Research Yamanaka:Yes. This morning, I ran around the Impe- rial Palace. But “every day” is an overstatement. I run Oku:Professor Yamanaka, I heard that your father en- about 260 days a year and a little less than 10 kilome- couraged you to become a medical doctor. ters (6.2 miles) a day. I also run full marathons to Yamanaka:Yes. That is true. My father used to run a raise donations for our lab a few times a year. small factory in Osaka. He suggested I should be a Oku:At what stage is your research on iPS cells? doctor because he thought I was not suited to run a Yamanaka:We are currently compiling an inventory of company. That he had an illness and a declining iPS cells.
    [Show full text]
  • Lasker Interactive Research Nom'18.Indd
    THE 2018 LASKER MEDICAL RESEARCH AWARDS Nomination Packet albert and mary lasker foundation November 1, 2017 Greetings: On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination for the 2018 Lasker Medical Research Awards. Since 1945, the Lasker Awards have recognized the contributions of scientists, physicians, and public citizens who have made major advances in the understanding, diagnosis, treatment, cure, and prevention of disease. The Medical Research Awards will be offered in three categories in 2018: Basic Research, Clinical Research, and Special Achievement. The Lasker Foundation seeks nominations of outstanding scientists; nominations of women and minorities are encouraged. Nominations that have been made in previous years are not automatically reconsidered. Please see the Nomination Requirements section of this booklet for instructions on updating and resubmitting a nomination. The Foundation accepts electronic submissions. For information on submitting an electronic nomination, please visit www.laskerfoundation.org. Lasker Awards often presage future recognition of the Nobel committee, and they have become known popularly as “America’s Nobels.” Eighty-seven Lasker laureates have received the Nobel Prize, including 40 in the last three decades. Additional information on the Awards Program and on Lasker laureates can be found on our website, www.laskerfoundation.org. A distinguished panel of jurors will select the scientists to be honored with Lasker Medical Research Awards. The 2018 Awards will
    [Show full text]
  • Recent Winners of the Nobel Medicine Prize 1 October 2018
    Recent winners of the Nobel Medicine Prize 1 October 2018 2015: William Campbell (US citizen born in Ireland) and Satoshi Omura (Japan), Tu Youyou (China) for unlocking treatments for malaria and roundworm. 2014: John O'Keefe (Britain, US), Edvard I. Moser and May-Britt Moser (Norway) for discovering how the brain navigates with an "inner GPS". 2013: Thomas C. Suedhof (US citizen born in Germany), James E. Rothman and Randy W. Schekman (US) for work on how the cell organises its transport system. 2012: Shinya Yamanaka (Japan) and John B. Gurdon (Britain) for discoveries showing how adult cells can be transformed back into stem cells. 2011: Bruce Beutler (US), Jules Hoffmann (French citizen born in Luxembourg) and Ralph Steinman (Canada) for work on the body's immune system. Credit: Wikipedia 2010: Robert G. Edwards (Britain) for the development of in-vitro fertilisation. 2009: Elizabeth Blackburn (Australia-US), Carol Here is a list of the winners of the Nobel Medicine Greider and Jack Szostak (US) for discovering how Prize in the past 10 years, after James Allison of chromosomes are protected by telomeres, a key the US and Tasuku Honjo of Japan were awarded factor in the ageing process. Monday for research that has revolutionised cancer treatment: © 2018 AFP 2018: Immunologists Allison and Honjo win for figuring out how to release the immune system's brakes to allow it to attack cancer cells more efficiently. 2017: US geneticists Jeffrey Hall, Michael Rosbash and Michael Young for their discoveries on the internal biological clock that governs the wake- sleep cycles of most living things.
    [Show full text]
  • Potential and Mentality of Genius and Inspiration and Milestone
    Crimson Publishers Research Article Wings to the Research Potential and Mentality of Genius and inspiration and milestone breakthroughs: longevity, diseases and Beyond Yue Zhang1,2,3* 1Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China 2Nobel Breakthroughs Inspiration Milestone Initiative, Pinghu Hospital of Shenzhen University, China 3Department of Rheumatology and Immunology, The First Clinical College of Harbin Medical University, China Abstract relatedThis diseases conceptual and beyond. study focusesIt aims to on help the promote evolving government field of potential strategy, andfostering the mentalityapprenticeships, of genius, and renewinginspiration ideas and aboutmilestone the role breakthroughs of family, hardship, alongside war, lines paradigm of stories shifts of andscientific religion life in of, developing longevity, geniusaging- and inspiration that will help make more groundbreaking discoveries in China. First, this essay reviews some of the factors that help stimulate, develop and inspire the leading scientists and researchers of the future. It then turns to some examples of inspired genius, before turning to my personal journey into the world of scientific research of longevity, aging-related diseases (e.g. *Corresponding author: Yue Zhang, some conclusions about how to inspire the prizewinning scientists of tomorrow’ China, even the world. Shenzhen Futian Hospital for Rheumatic Alzheimer’s diseases, Huntington’s diseases, cancer, Osteoarthritis (OA)) and beyond. We finish with Diseases, Shenzhen, #22 Nonglin road, China. Emai: [email protected] Factors Fostering Genius and Inspiration Numerous factors appear to be important in developing the brilliant scientists who make Submission: March 31, 2020 breakthrough discoveries. Here, we give only a brief review of each for reasons of space, as Published: April 22, 2020 large amounts of literature could be written on each one.
    [Show full text]
  • Nobel Laureates in Physiology Or Medicine
    All Nobel Laureates in Physiology or Medicine 1901 Emil A. von Behring Germany ”for his work on serum therapy, especially its application against diphtheria, by which he has opened a new road in the domain of medical science and thereby placed in the hands of the physician a victorious weapon against illness and deaths” 1902 Sir Ronald Ross Great Britain ”for his work on malaria, by which he has shown how it enters the organism and thereby has laid the foundation for successful research on this disease and methods of combating it” 1903 Niels R. Finsen Denmark ”in recognition of his contribution to the treatment of diseases, especially lupus vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science” 1904 Ivan P. Pavlov Russia ”in recognition of his work on the physiology of digestion, through which knowledge on vital aspects of the subject has been transformed and enlarged” 1905 Robert Koch Germany ”for his investigations and discoveries in relation to tuberculosis” 1906 Camillo Golgi Italy "in recognition of their work on the structure of the nervous system" Santiago Ramon y Cajal Spain 1907 Charles L. A. Laveran France "in recognition of his work on the role played by protozoa in causing diseases" 1908 Paul Ehrlich Germany "in recognition of their work on immunity" Elie Metchniko France 1909 Emil Theodor Kocher Switzerland "for his work on the physiology, pathology and surgery of the thyroid gland" 1910 Albrecht Kossel Germany "in recognition of the contributions to our knowledge of cell chemistry made through his work on proteins, including the nucleic substances" 1911 Allvar Gullstrand Sweden "for his work on the dioptrics of the eye" 1912 Alexis Carrel France "in recognition of his work on vascular suture and the transplantation of blood vessels and organs" 1913 Charles R.
    [Show full text]
  • Nobel Laureates Published In
    Nobel Laureates Published in Science has published the research of over 400 Laureates since the award’s inception in 1901! Award categories include Chemistry, Physics, and Medicine. Listed here are prize-winning authors from 1990 to the present, with the number of articles each Laureate published in Science. MEDICINE Articles CHEMISTRY Articles PHYSICS Articles 2015 2016 2014 William C. Campbell . 2 Ben Feringa —Netherlands........................5 Shuji Namakura—Japan .......................... 1 J. Fraser Stoddart—UK . 7 2014 2012 John O’Keefe—US...................................3 2015 Serge Haroche—France . 1 May-Britt Moser—Norway .......................11 Tomas Lindahl—US .................................4 David J. Wineland—US ............................12 Edvard I. Moser—Norway ........................11 Paul Modrich—US...................................4 Aziz Sancar—US.....................................7 2011 2013 Saul Perlmutter—US ............................... 1 2014 James E. Rothman—US ......................... 10 Brian P. Schmidt—US/Australia ................. 1 Eric Betzig—US ......................................9 Randy Schekman—US.............................5 Stefan W. Hell—Germany..........................6 2010 Thomas C. Südhof—Germany ..................13 William E. Moerner—US ...........................5 Andre Geim—Russia/UK..........................6 2012 Konstantin Novoselov—Russia/UK ............5 2013 Sir John B. Gurdon—UK . 1 Martin Karplas—Austria...........................4 2007 Shinya Yamanaka—Japan.........................3
    [Show full text]
  • Ssfaoggi 201306
    SOCIETA’ DI SCIENZE FARMACOLOGICHE APPLICATE SOCIETY FOR APPLIED PHARMACOLOGICAL SSFAoggi SCIENCES Notiziario di Medicina Farmaceutica Giugno 2013 Bimestrale della Società di Scienze Farmacologiche Applicate Fondata nel 1964 numero 37 Dove sono i nuovi antibiotici? Sommario: La comunità mondiale sta correndo un grosso rischio: questo ci ricordano due editoriali, Editoriale 1 pubblicati su The Lancet e sul British Medical Journal, che riportiamo alle pagine 21 e 22. La resistenza agli antibiotici è un grave problema: The Lancet ci ricorda che fu addirittura Novità in Farmacovigilanza messa in evidenza dallo stesso Alexander Fleming nel 1945, il quale temeva che l’abuso Parte prima 2 della penicillina potesse selezionare ceppi resistenti. Il British Medical Journal evidenzia che molte pratiche mediche e chirurgiche (dall’uso Novità in Farmacovigilanza della chemioterapia agli interventi invasivi in ortopedia e cardiochirurgia) sono possibili Parte seconda 4 grazie alla profilassi con antibiotici. E quindi, la resistenza agli antibiotici non è un solo un problema degli infettivologi, ma sta diventando un problema dei chirurghi, degli oncologi, e Il Decreto Balduzzi 6 di tutto il sistema sanitario. Alcune previsioni sono drammatiche: l’intervento di protesi dell’anca, che è diventato una Farmaci a brevetto scaduto 12 routine per la popolazione anziana, potrebbe essere colpito in modo significativo da com- plicanze infettive, passando dall’1% dei pazienti di oggi fino al 40%-50% dei pazienti nel Affari Istituzionali 12 prossimo futuro, con oltre un terzo di essi in pericolo di vita. Uno scenario davvero preoc- 5a Edizione Master Bicocca 13 cupante. Di fronte a queste previsioni, che ci vengono ormai ripetute ad intervalli regolari, stupisce Master Bicocca 2013: i numeri 13 la mancanza di incentivi per la ricerca di nuovi antibiotici.
    [Show full text]
  • SWOSU Biology Seniors Showcasing Works on April 22-24
    SWOSU Biology Seniors Showcasing Works on April 22-24 04.19.2013 Biology majors in the senior seminar course at Southwestern Oklahoma State University will present posters April 22-24 on the Weatherford campus. The theme of this semester’s posters is “Celebrating 2000-2012 Nobel Laureates in Physiology or Medicine.” The presentations will be held on the second floor of the Old Science Building. Posters will be available for viewing from 9 a.m. through 5 p.m. each day. Student authors will be available from 4-5 p.m. on Monday, April 22. The public is invited and encouraged to attend. Poster topics and presenters are: • 2012, Sir John B. Gurdon, Shinya Yamanaka Nobel Laureates"for the discovery that mature cells can be reprogrammed to become pluripotent" by Melissa Peters, Geary. • 2011, Bruce A. Beutler, Jules A. Hoffmann, Ralph M. Steinman Nobel Laureates "for their discoveries concerning the activation of innate immunity" and the other half to Ralph M. Steinman "for his discovery of the dendritic cell and its role in adaptive immunity" by Maria Ortega, Guymon. • 2010, Robert G. Edwards Nobel Laureate"for the development of in vitro fertilization" by Shannah Rider, Mustang. • 2009, Elizabeth H. Blackburn, Carol W. Greider, Jack W. SzostakNobel Laureates "for the discovery of how chromosomes are protected by telomeres and the enzyme telomerase" by Kimberly Madrid, Lovington (NM). • 2008, HaraldzurHausen, Françoise Barré-Sinoussi, Luc MontagnierNobel Laureates "for his discovery of human papilloma viruses causing cervical cancer", the other half jointly to Françoise Barré-Sinoussi and Luc Montagnier"for their discovery of human immunodeficiency virus"by Kasey McFalls, Okmulgee.
    [Show full text]
  • Nobel Laureate Dr. Shinya Yamanaka
    Nobel Laureate Dr. Shinya Yamanaka Dr. Shinya Yamanaka was awarded the 2012 Nobel Prize in Physiology or Medicine jointly with Sir John B. Gurdon “for the discovery that mature cells can be reprogrammed to become pluripotent” Dr. Shinya Yamanaka and his research team reported the world’s fi rst generation of mouse iPS cells in 2006 and the generation of human iPS cells in 2007. The team also reported the establishment of mouse iPS cells using plasmid DNA vectors in 2008, one of the first methods to generate such cells without requiring gene insertion. Many researchers around the world are now working on studies with the use of iPS cells, which may one Dr. Shinya Yamanaka day fi nd applications in regenerative medicine and Director and Professor as a research tool in drug discovery. In order for Center for iPS Cell Research and Application (CiRA) such applications to become a reality, however, it Principal Investigator, will be necessary to establish optimal protocols for Institute for Integrated Cell-Material Sciences (iCeMS) the generation of iPS cells by deepening our understanding of the mechanisms that underlie the Dr. Shinya Yamanaka received his M.D. reprogramming of differentiated cells into an from Kobe University in 1987 and his Ph.D. undifferentiated state. from Osaka City University in 1993. After working as a postdoctoral fellow at the Dr. Yamanaka commented that he is particularly Gladstone Institute of Cardiovascular Disease happy to have been awarded the prize jointly with in San Francisco, he became an assistant Sir John B. Gurdon, a Fellow of the Royal Society professor at Osaka City University in 1996.
    [Show full text]
  • Laureatai Pagal Atradimų Sritis
    1 Nobelio premijų laureatai pagal atradimų sritis Toliau šioje knygoje Nobelio fiziologijos ir medicinos premijos laureatai suskirstyti pagal jų atradimus tam tikrose fiziologijos ir medicinos srityse. Vienas laureatas gali būti įrašytas keliose srityse. Akies fiziologija 1911 m. Švedų oftalmologas Allvar Gullstrand – už akies lęšiuko laužiamosios gebos tyrimus. 1967 m. Suomių ir švedų neurofiziologas Ragnar Arthur Granit, amerikiečių fiziologai Haldan Keffer Hartline ir George Wald – už akyse vykstančių pirminių fiziologinių ir cheminių procesų atradimą. Antibakteriniai vaistai 1945 m. Škotų mikrobiologas seras Alexander Fleming, anglų biochemikas Ernst Boris Chain ir australų fiziologas seras Howard Walter Florey – už penicilino atradimą ir jo veiksmingumo gydant įvairias infekcijas tyrimus. 1952 m. Amerikiečių mikrobiologas Selman Abraham Waksman – už streptomicino, pirmojo efektyvaus antibiotiko nuo tuberkuliozės, sukūrimą. Audiologija 1961 m. Vengrų biofizikas Georg von Békésy – už sraigės fizinio dirginimo mechanizmo atradimą. Bakteriologija 1901 m. Vokiečių fiziologas Emil Adolf von Behring – už serumų terapijos darbus, ypač pritaikius juos difterijai gydyti (difterijos antitoksino sukūrimą). 1905 m. Vokiečių bakteriologas Heinrich Hermann Robert Koch – už tuberkuliozės tyrimus ir atradimus. 1928 m. Prancūzų bakteriologas Charles Jules Henri Nicolle – už šiltinės tyrimus. 1939 m. Vokiečių bakteriologas Gerhard Johannes Paul Domagk – už prontozilio antibakterinio veikimo atradimą. 1945 m. Škotų mikrobiologas Alexander Fleming, anglų biochemikas Ernst Boris Chain ir australų fiziologas Howard Walter Florey – už penicilino atradimą ir jo veiksmingumo gydant įvairias infekcijas tyrimus. 1952 m. Amerikiečių mikrobiologas Selman Abraham Waksman – už streptomicino, pirmojo efektyvaus antibiotiko nuo tuberkuliozės, sukūrimą. 2005 m. 2 Australų mikrobiologas Barry James Marshall ir australų patologas John Robin Warren – už bakterijos Helicobacter pylori atradimą ir jos įtakos skrandžio ir dvylikapirštės žarnos opos atsivėrimui nustatymą.
    [Show full text]